In accordance with applicable privacy legislation, the company Kedrion S.p.a., controller of the data acquired via this website, hereby informs the user that said website does not use profiling cookies to send advertising messages tuned to preferences expressed when browsing the internet. This website installs third party cookies. Continuing to browse, including by scrolling down and clicking on website elements, equates to consent.
For more information, also as regards the technical cookies used by the website and to refuse consent to the installation of individual cookies, please refer to the complete cookies disclosure.
You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
-
CORPORATE - 03-06-2011
Kedrion reinforces its presence in the US. Closed acquisition of Grifols' assets. Incorporation of the new Kedrion Biopharma
read more -
CORPORATE - 05-05-2011
Agreements between Kedrion and Grifols
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 